Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ina Liko

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmacogenomics|July 8, 2017
Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirementAlison Lh Quinn, Ina Liko, James C Lee
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 27, 2021
Implementation of a pharmacist-provided pharmacogenomics service in an executive health programIna Liko, Lisa Corbin, Eric Tobin, et al.
Pharmacopsychiatry|June 26, 2020
Patients' Perspectives on Psychiatric Pharmacogenetic TestingIna Liko, Erika Lai, Rachel J Griffin, et al.
JAMA|October 26, 2018
Association of Genetic Variants With Warfarin-Associated Bleeding Among Patients of African DescentTanima De, Cristina Alarcon, Wenndy Hernandez, et al.
Pharmacogenomics|March 4, 2021
Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patientsIna Liko, Yee Ming Lee, Danielle L Stutzman, et al.
Pharmacogenomics|February 21, 2020
Clinical implementation of pharmacogenomics via a health system-wide research biobank: the University of Colorado experienceChristina L Aquilante, David P Kao, Katy E Trinkley, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmacogenomics|July 8, 2017
Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirementAlison Lh Quinn, Ina Liko, James C Lee
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 27, 2021
Implementation of a pharmacist-provided pharmacogenomics service in an executive health programIna Liko, Lisa Corbin, Eric Tobin, et al.
Pharmacopsychiatry|June 26, 2020
Patients' Perspectives on Psychiatric Pharmacogenetic TestingIna Liko, Erika Lai, Rachel J Griffin, et al.
JAMA|October 26, 2018
Association of Genetic Variants With Warfarin-Associated Bleeding Among Patients of African DescentTanima De, Cristina Alarcon, Wenndy Hernandez, et al.
Pharmacogenomics|March 4, 2021
Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patientsIna Liko, Yee Ming Lee, Danielle L Stutzman, et al.
Pharmacogenomics|February 21, 2020
Clinical implementation of pharmacogenomics via a health system-wide research biobank: the University of Colorado experienceChristina L Aquilante, David P Kao, Katy E Trinkley, et al.
Pageof 1